The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.
How Trump's psychedelics executive order could unlock stalled cannabis reform
Key Takeaways
Read this first — then go as deep as you need.
Discussion
Loading comments...
Enjoying this article?
Get more like it delivered to your inbox — free.
This article was compiled by GlobalSell News from publicly available reporting and has been edited for clarity and length. For full details, read the original source.